Feo F - Search Results

1

Alterations of Methionine Metabolism as Potential Targets for the Prevention and Therapy of Hepatocellular Carcinoma.

Pascale RM, Peitta G, Simile MM, Feo F. Pascale RM, et al. Among authors: feo f. Medicina (Kaunas). 2019 Jun 21;55(6):296. doi: 10.3390/medicina55060296. Medicina (Kaunas). 2019. PMID: 31234428 Free PMC article. Review.

2

Chemoprevention of hepatocarcinogenesis: S-adenosyl-L-methionine.

Pascale RM, Simile MM, De Miglio MR, Feo F. Pascale RM, et al. Among authors: feo f. Alcohol. 2002 Jul;27(3):193-8. doi: 10.1016/s0741-8329(02)00227-6. Alcohol. 2002. PMID: 12163149 Review.

3

Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-{kappa}B and Mat1A genes in the early stages of rat liver carcinogenesis.

Simile MM, Pagnan G, Pastorino F, Brignole C, De Miglio MR, Muroni MR, Asara G, Frau M, Seddaiu MA, Calvisi DF, Feo F, Ponzoni M, Pascale RM. Simile MM, et al. Among authors: feo f. Carcinogenesis. 2005 Feb;26(2):417-27. doi: 10.1093/carcin/bgh315. Epub 2004 Oct 21. Carcinogenesis. 2005. PMID: 15498786

4

Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis.

Calvisi DF, Simile MM, Ladu S, Pellegrino R, De Murtas V, Pinna F, Tomasi ML, Frau M, Virdis P, De Miglio MR, Muroni MR, Pascale RM, Feo F. Calvisi DF, et al. Among authors: feo f. Int J Cancer. 2007 Dec 1;121(11):2410-20. doi: 10.1002/ijc.22940. Int J Cancer. 2007. PMID: 17680562 Free article.

5

Dissection of signal transduction pathways as a tool for the development of targeted therapies of hepatocellular carcinoma.

Calvisi DF, Pascale RM, Feo F. Calvisi DF, et al. Among authors: feo f. Rev Recent Clin Trials. 2007 Sep;2(3):217-36. doi: 10.2174/157488707781662715. Rev Recent Clin Trials. 2007. PMID: 18474008 Review.

6

Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma.

Feo F, Frau M, Tomasi ML, Brozzetti S, Pascale RM. Feo F, et al. Exp Biol Med (Maywood). 2009 Jul;234(7):726-36. doi: 10.3181/0901-MR-40. Epub 2009 May 8. Exp Biol Med (Maywood). 2009. PMID: 19429855 Review.

7

Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.

Frau M, Biasi F, Feo F, Pascale RM. Frau M, et al. Among authors: feo f. Mol Aspects Med. 2010 Apr;31(2):179-93. doi: 10.1016/j.mam.2010.02.007. Epub 2010 Feb 20. Mol Aspects Med. 2010. PMID: 20176048 Review.

8

Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.

Frau M, Ladu S, Calvisi DF, Simile MM, Bonelli P, Daino L, Tomasi ML, Seddaiu MA, Feo F, Pascale RM. Frau M, et al. Among authors: feo f. J Hepatol. 2011 Jul;55(1):111-9. doi: 10.1016/j.jhep.2010.10.031. Epub 2010 Dec 7. J Hepatol. 2011. PMID: 21419759

9

Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.

Frau M, Tomasi ML, Simile MM, Demartis MI, Salis F, Latte G, Calvisi DF, Seddaiu MA, Daino L, Feo CF, Brozzetti S, Solinas G, Yamashita S, Ushijima T, Feo F, Pascale RM. Frau M, et al. Among authors: feo cf, feo f. Hepatology. 2012 Jul;56(1):165-75. doi: 10.1002/hep.25643. Epub 2012 Jun 5. Hepatology. 2012. PMID: 22318685

10

An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis.

Frau M, Simile MM, Tomasi ML, Demartis MI, Daino L, Seddaiu MA, Brozzetti S, Feo CF, Massarelli G, Solinas G, Feo F, Lee JS, Pascale RM. Frau M, et al. Among authors: feo cf, feo f. Cell Oncol (Dordr). 2012 Jun;35(3):163-73. doi: 10.1007/s13402-011-0067-z. Epub 2012 Mar 21. Cell Oncol (Dordr). 2012. PMID: 22434528 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page